You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Amlodipine or lisinopril was not better than chlorthalidone for reducing CVD risk in hypertensive black or non-black patients

Article Text

Article menu
Download PDFPDF
Therapeutics
Amlodipine or lisinopril was not better than chlorthalidone for reducing CVD risk in hypertensive black or non-black patients

https://doi.org/10.1136/ebm.10.6.170

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • ↵† The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    • For correspondence: Dr J T Wright Jr, Case Western Reserve University, Cleveland, OH, USA. jackson.wright{at}case.edu

    • Source of funding: National Heart, Lung, and Blood Institute.